Consensus guidelines reached regarding pregnancy and MS
Key points to take from the guidance include:
- Treatment with disease-modifying drugs should not be delayed until a woman with multiple sclerosis (MS) has completed her family.
- Consider the possibility of pregnancy when prescribing to all women with MS of childbearing age.
- Relapse rate reduces naturally during pregnancy, and so many women with MS choose to stop disease-modifying drugs when they become pregnant—however, for those with very active MS, treatment throughout pregnancy should be considered.
- If relapse occurs, corticosteroids can be given during pregnancy and while breastfeeding.
- Having MS does not automatically make pregnancy high risk and should not in itself limit birthing options.
Really happy to see this in print - lots of work to attempt to reach a meaningful consensus. Hopefully useful for both clinicians and patients @BartsMSBlog @GavinGiovannoni @nelson_piercy @PoojaDassan @MSTrust @mssocietyuk https://t.co/cyUsowFG0u— Ruth Dobson (@drruthdobson) 6 January 2019
For more information
Encouraging excellence, developing leaders, inspiring change
MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.